Receiving a myelodysplastic syndromes (MDS) diagnosis isn’t easy, and talking with your family about it can feel overwhelming. Here’s what you need to know to answer some of the most common questions.

Results from a retrospective study compared and explored biomarkers associated with outcomes in myelodysplastic syndrome (MDS) with plasma cell neoplasms. MDS is a group of heterogeneous clonal ...

It is possible, if you lay the groundwork, to provide patients with acute leukemias with aggressive and effective therapies, while still allowing them to maintain quality of life, explained Jennifer ...